# Blockchain for Clinical Trial Management

> Pfizer explores the use of blockchain technology to improve integrity and transparency in clinical trials. The technology enables secure management of electronic patient consent, tamper-proof storage of research data, and increased auditability of the entire study process. Pfizer is already part of IBM's Food Trust Blockchain network and works with other pharmaceutical companies on blockchain solutions for supply chain transparency.

**Sector:** Tertiary sector · **Industry:** Pharmaceutical sales and services · **Organisation:** Pfizer · **Maturity level:** Concept

Canonical URL: https://www.sapientblock.com/en/use-cases/pfizer-klinische-studien-digital-verwalten

## Documentation status

- **Project status:** Concept
- **Evidence:** Evidence medium
- **Editorial review:** Ufuk Avci, 15 April 2026

## Description

Clinical trials have several critical integrity issues that undermine scientific reproducibility and trust in pharmaceutical research. Blockchain-based study management systems address these structurally.

The main problems of clinical trials: (1) Protocol changes: primary endpoints can be changed after data review — HARKing (Hypothesising After Results are Known). (2) Selective publication: negative results are less frequently published. (3) Data falsification: individual data points can be manipulated in central systems. Blockchain solves all three: the study protocol is anchored on the blockchain before the study begins (timestamp); each patient consent is digitally signed and stored immutably; all data entries have cryptographic timestamps. Triall (Netherlands) is a specialised clinical trial platform used as primary data governance in over 8,000 studies. Embleema (USA, PMC article describes the approach) offers blockchain-based clinical research with direct FDA engagement: the FDA-approved infrastructure accelerates the regulatory approval process. Regulatory: FDA 21 CFR Part 11 (Electronic Records) and EMA Guideline on Computerised Systems require verifiable audit trails — blockchain is the natural answer.

## Benefits

- Reduced compliance costs through automated and immutable documentation of all regulatory requirements.
- Increased transparency about the use of personal health data strengthens patients' trust in clinical trials.
- Tamper-proof storage of all study data increases regulators' trust and accelerates approval processes.
- Transparent logging of all patient consents and data changes reduces regulatory risks.
- Decentralised study architecture enables a global participant base and more efficient recruitment of study participants.
- Automated data logging reduces manual documentation work and allows focus on the actual research activity.

## Challenges

- High implementation costs for blockchain infrastructure and staff training can disadvantage smaller pharmaceutical companies.
- Integration with existing clinical study management systems requires significant technical adjustments and investments.
- Regulatory recognition of blockchain-based study data is not yet fully established in all jurisdictions.
- Required technical training for blockchain technology can cause resistance among established researchers.

## Technology foundation

Blockchain technology creates an immutable digital ledger in which all transactions and data changes are permanently recorded. This feature makes it ideal for clinical trials, as it enables tamper-proof records of patient consents, study results, and data modifications.

## Sources

- [Blockchain Applications in Pharmaceutical Industry](https://research-source.com)